Cargando…
Should patients with acute exacerbation of chronic bronchitis be treated with antibiotics? Advantages of the use of fluoroquinolones
The pathological changes in chronic bronchitis (CB) produce airflow obstruction, reduce the effectiveness of the mucocilliary drainage system and lead to bacterial colonisation of bronchial secretion. The presence of bacteria induces an inflammatory response mediated by leukocytes. There is a direct...
Autores principales: | Mensa, J., Trilla, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128137/ https://www.ncbi.nlm.nih.gov/pubmed/16669928 http://dx.doi.org/10.1111/j.1469-0691.2006.01396.x |
Ejemplares similares
-
Fluoroquinolone-Resistant Group B Streptococci in Acute Exacerbation of Chronic Bronchitis
por: Tazi, Asmaa, et al.
Publicado: (2008) -
Gemifloxacin use in the treatment of acute bacterial exacerbation of chronic bronchitis
por: Jivcu, Cristian, et al.
Publicado: (2009) -
Infection in acute exacerbations of chronic bronchitis: a clinical perspective
por: Read, R.C.
Publicado: (1999) -
Newer fluoroquinolones in the treatment of acute exacerbations of COPD
por: Patel, Amit, et al.
Publicado: (2006) -
Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD
por: Miravitlles, Marc
Publicado: (2007)